The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Originally identified in Drosophila melanogaster, the Warts(Wts)/Lats protein kinase has been proposed to function with two other Drosophila proteins, Hippo (Hpo) and Salvador (Sav), in the regulation of cell cycle exit and apoptosis. In mammals, two candidate Warts/Lats homologs, termed Lats1 and Lats2, have been described, and the targeted disruption of LATS1 in mice increases tumor formation. Little, however, is known about the function and regulation of human Lats kinases. Here we report that human Mst2, a STE20-family member and purported Hpo ortholog, phosphorylates and activates both Lats1 and Lats2. Deletion analysis revealed that regulation of Lats1 occurs through the C-terminal, catalytic domain. Within this domain, two regulatory phosphorylation sites were identified by mass spectrometry. These sites, S909 in the activation loop and T1079 within a hydrophobic motif, have been highly conserved during evolution. Moreover, a direct interaction was observed between Mst2 and hWW45, a putative ortholog of Drosophila Sav. These results indicate that Mst2-like kinases regulate Lats kinase activities in an evolutionarily conserved regulatory pathway. Although the function of this pathway remains poorly understood in mammals, it is intriguing that, in Drosophila, it has been linked to development and tissue homeostasis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, LATS1 requires phosphorylation to be active [105] and LATS1 phosphorylation was increased on the non-acetylated, less stable LATS1K751R [104].”
From Acetylation: a new target for protein degradation in cancer (2025) · cites this paper as [105]
Citations
Cites
Mass Spectrometric Sequencing of Proteins from Silver-Stained Polyacrylamide Gels
Shevchenko, A., Wilm, M., Vorm, O., & Mann, M. (1996) · Analytical Chemistry · doi:10.1021/ac950914h · Cited by 8,995
Genomic Libraries and a Host Strain Designed for Highly Efficient Two-Hybrid Selection in Yeast
James, P., Halladay, J., & Craig, E. A. (1996) · Genetics · doi:10.1093/genetics/144.4.1425 · Cited by 2,637
Active and Inactive Protein Kinases: Structural Basis for Regulation
Johnson, L. N., Noble, M. E. M., & Owen, D. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81092-2 · Cited by 1,403 · cited 2×
“Interestingly, these sites are located within the activation loop (S909) and a hydrophobic motif (T1079), two domains previously been implicated in the activation of other kinases (Johnson et al., 1996; Tamaskovic et al., 2003).”
Okadaic acid: a new probe for the study of cellular regulation
Cohen, P., Holmes, C. F. B., & Tsukitani, Y. (1990) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(90)90192-e · Cited by 1,387
Wu, S., Huang, J., Dong, J., & Pan, D. (2003) · Cell · doi:10.1016/s0092-8674(03)00549-x · Cited by 1,098 · cited 10×
“When expressed in Drosophila, Mst2 was able to rescue the hpomutant phenotype, showing that it can act as a functional ortholog (Wu et al., 2003).”
BackgroundResultInfluentialDammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Justice, R. W., Zilian, O., Woods, D. F., Noll, M., & Bryant, P. J. (1995) · Genes & Development · doi:10.1101/gad.9.5.534 · Cited by 977
The Drosophila Mst Ortholog, hippo, Restricts Growth and Cell Proliferation and Promotes Apoptosis
Harvey, K. F., Pfleger, C. M., & Hariharan, I. K. (2003) · Cell · doi:10.1016/s0092-8674(03)00557-9 · Cited by 976 · cited 7×
“These data suggested that Wts/Lats, Sav and Hpo might form a trimeric complex in which Sav functions as an adaptor protein to bring Wts/Lats in close proximity to Hpo (Harvey et al., 2003).”
BackgroundResultInfluentialTapon, N., Harvey, K. F., Bell, D. W., Wahrer, D. C. R., Schiripo, T. A., Haber, D. A., & Hariharan, I. K. (2002) · Cell · doi:10.1016/s0092-8674(02)00824-3 · Cited by 856 · cited 7×
“…neither the N-terminally located putative UBA domain, a structure believed to bind ubiquitin moieties (Buchberger, 2002), nor the PPXY motifs, previously implicated in mediating the interaction between Wts/lats and Sav in Drosophila (Tapon et al., 2002), were required for this regulation.”
BackgroundResultInfluentialXu, T., Wang, W., Zhang, S., Stewart, R. A., & Yu, W. (1995) · Development · doi:10.1242/dev.121.4.1053 · Cited by 799
Cited by
Items 401–500 of 604
Shea, C. A., Rolfe, R. A., McNeill, H., & Murphy, P. (2019) · Developmental Dynamics · doi:10.1002/dvdy.137 · Cited by 16
Goel, H., Mathur, R., Syeda, S., Shrivastava, A., & Jha, A. K. (2021) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2021.22.3.977 · Cited by 14
“LATS1 Gene is linked with mitotic events in mammalian cells, and that loss of its function interrupts normal cell cycle regulation, leading to the development of Tumors (Chan et al., 2005).”
BackgroundChen, T., Sun, D., Wang, Q., Zhou, T., Tan, J., Xu, C., Cheng, H., & Shen, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.839603 · Cited by 17
Thines, L., Gorisse, L., Li, Z., Sayedyahossein, S., & Sacks, D. B. (2022) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2022.101839 · Cited by 16
“Tubulin Sigma—T5201 (079M4869V) 1:1000 (WB) GAPDH Cell Signaling—2118S (5) 1:1000 (WB)”
BackgroundInfluentialStructural dissection of Hippo signaling
Shi, Z., Jiao, S., & Zhou, Z. (2015) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmu107 · Cited by 14
“The Hippo pathway is highly conserved in mammals, and its corresponding components are mammalian sterile 20 (STE20)-like protein kinase 1/2 (MST1/2), Salvador homolog 1 (SAV1, also known as 45 kDa WW domain protein or WW45), large tumor suppressor homolog 1/2 (LATS1/2), MOB kinase activator 1A/B (MOB1A/B), and Yesasso…”
BackgroundDokla, E. M. E., Fang, C., Chu, P., Chang, C., Abouzid, K. A. M., & Chen, C. S. (2020) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.9b00501 · Cited by 15
Increasing kinase domain proximity promotes MST2 autophosphorylation during Hippo signaling
Tran, T. T., Mitra, J., Ha, T., & Kavran, J. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.015723 · Cited by 13
Shields, C. E., Potlapalli, S., Cuya-Smith, S. M., Chappell, S. K., Chen, D., Martínez, D., Pogoriler, J. E., Rathi, K. S., Patel, S. A., Oristian, K. M., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.12914 · Cited by 15
Clinical potential of the Hippo-YAP pathway in bladder cancer
Cheng, X., Lou, K., Ding, L., Zou, X., Huang, R., Xu, G., Zou, J., & Zhang, G. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.925278 · Cited by 13
Hippo and PI5P4K signaling intersect to control the transcriptional activation of YAP
Palamiuc, L., Johnson, J. L., Haratipour, Z., Loughran, R. M., Choi, W. J., Arora, G. K., Tieu, V., Ly, K., Lope, A. L., Crabtree, S., et al. (2024) · Science Signaling · doi:10.1126/scisignal.ado6266 · Cited by 13
“The best-characterized substrates for MST1/2 are MOB1A, MOB1B ( 23 , 24 ), LATS1, and LATS2 ( 25 ), the core members of the classical Hippo cascade.”
BackgroundYoo, G., Kim, T., Chung, C., Hwang, D.-S., & Lim, D. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.092 · Cited by 14
Sun, C., He, B., Sun, M., Lv, X., Wang, F., Chen, J., Zhang, J., Ye, Z., Wen, J., & Liu, P. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.704208 · Cited by 13
Liu, Y., He, E., Zhang, Y., Liu, Y., Wang, Y., Chen, S., Wu, X., Zeng, Y., & Leng, P. (2022) · Gland Surgery · doi:10.21037/gs-22-716 · Cited by 12
“Researchers have summarized the signaling axis of MST1/2SAV1-WWC1/2/3-LATS1/2-YAP/TAZ (76).”
InfluentialComplex interplay between RAS GTPases and RASSF effectors regulates subcellular localization of YAP
Singh, S., Astrain, G. B., Hincapie, A. M., Goudreault, M., & Smith, M. J. (2024) · EMBO Reports · doi:10.1038/s44319-024-00203-9 · Cited by 14
“The core of the pathway comprises a kinase cascade wherein the serine/threonine kinases MST1/2 (orthologs of Drosophila hippo/Hpo), along with their partner SAV phosphorylate and activate LATS1/2 and their co-factor MOB1A/B (Yu and Guan, 2013; Chan et al, 2005).”
Analysis of Altered Micro RNA Expression Profiles in Focal Cortical Dysplasia IIB
Li, L., Liu, C., Li, T., Guan, Y., Zhou, J., Qi, X., Yang, Y., Deng, J., Xu, Q., & Luan, G. (2015) · Journal of Child Neurology · doi:10.1177/0883073815609148 · Cited by 13
Huang, P. Y., & Xue, J. (2020) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2020.4699 · Cited by 12
Hum, M., Tan, H. J., Yang, Y., Srivastava, S., Teh, M., & Lim, Y. P. (2021) · The FASEB Journal · doi:10.1096/fj.202000393r · Cited by 12
Antón, I. M., & Wandosell, F. G. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673986 · Cited by 12
Safeguarding genome stability: RASSF1A tumor suppressor regulates BRCA2 at stalled forks
Pefani, D., & O’Neill, E. E. (2015) · Cell Cycle · doi:10.1080/15384101.2015.1035845 · Cited by 12
“activation depends on the MST1/2 (Hippo orthologues in mammals), which mediate LATS1 phosphorylation at S909 and T1079 leading to conformational changes and kinase activity stimulation.(33) Intriguingly, LATS1 was identified in a proteomic analysis for novel pathways that respond to ATM/ATR stimulation and maintain ge…”
BackgroundChernoff, J. (2008) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a001347.01 · Cited by 11
Strategies that regulate Hippo signaling pathway for novel anticancer therapeutics
Li, N., Liu, Y., Wu, J. Y., Liu, Q.-G., Niu, J.-B., Zhang, Y., Fu, X.-J., Song, J. H., & Zhang, S. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116694 · Cited by 12
SUMOylation of Warts kinase promotes neural stem cell reactivation
Gao, Y., Tan, Y. S., Lin, J., Chew, L. Y., Aung, H. Y., Palliyana, B., Gujar, M. R., Lin, K., Kondo, S., & Wang, H. (2024) · Nature Communications · doi:10.1038/s41467-024-52569-y · Cited by 11
Jin, F., Ni, X., Yu, S., Jiang, X., Shi, X., Zhou, J. Y., Mao, D., Wang, H., Liu, Y., & Wu, F. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154761 · Cited by 13
POPX2 is a novel LATS phosphatase that regulates the Hippo pathway
Rahmat, M. B. B., Zhang, S., & Koh, C.-G. (2019) · Oncotarget · doi:10.18632/oncotarget.26689 · Cited by 11
“Similarly, Ser909 and Thr1079 of LATS1 are identified to be phosphorylated by MST2 and essential for LATS1 kinase activity [22].”
The clinical relevance of the Hippo pathway in pancreatic ductal adenocarcinoma
Drexler, R., Küchler, M., Wagner, K. C., Reese, T., Feyerabend, B., Kleine, M., & Oldhafer, K. J. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03427-z · Cited by 12
Drug-Resistant Breast Cancer: Dwelling the Hippo Pathway to Manage the Treatment
Kaur, S., Najm, M. Z., Khan, M. A., Akhter, N., Shingatgeri, V., Sikenis, M., Sadaf, S., & Aloliqi, A. A. (2021) · Breast Cancer Targets and Therapy · doi:10.2147/bctt.s343329 · Cited by 13
Phosphorylation analysis of the Hippo-YAP pathway using Phos-tag
Kim, C.-L., Lim, S., Kim, K., Jeong, H.-S., & Mo, J. (2022) · Journal of Proteomics · doi:10.1016/j.jprot.2022.104582 · Cited by 11
Phase separation in immune regulation and immune-related diseases
Huang, N., Dong, H., & Shao, B. (2022) · Journal of Molecular Medicine · doi:10.1007/s00109-022-02253-9 · Cited by 11
Cairns, L. S., Patterson, A., Weingartner, K. A., Koehler, T. J., DeAngelis, D. R., Tripp, K. W., Bothner, B. B., & Kavran, J. M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.012679 · Cited by 12
CORO7 functions as a scaffold protein for the core kinase complex assembly of the Hippo pathway
Park, J., Jun, K., Choi, Y., Yoon, E., Kim, W., Jang, Y., & Chung, J. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.013297 · Cited by 13
Apical junctions and growth control in Drosophila
Badouel, C., & McNeill, H. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.08.026 · Cited by 13
“Whereas it was at first studied only in Drosophila, there is now growing evidence that the Hippo pathway is well conserved in mammals where it is also involved in the restriction of tissue growth and organ size [12,11,15,80,26].”
BackgroundThe Hippo signaling pathway as a therapeutic target in Alzheimer’s disease
Chen, D., Wigglesworth-Littlewood, S., & Gunn, F. J. (2025) · Molecular Neurodegeneration · doi:10.1186/s13024-025-00891-4 · Cited by 15
“During active Hippo signaling, MST1/2 kinases form a complex with SAV1 to phosphorylate and activate LATS1/2 kinases [35], which subsequently form a complex with MOB1 [269].”
Using Biosensors to Study Protein–Protein Interaction in the Hippo Pathway
Pipchuk, A., & Yang, X. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.660137 · Cited by 10
Structural and Biochemical Analyses of the Core Components of the Hippo Pathway
Ni, L., & Luo, X. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8910-2_18 · Cited by 11
Cai, Z., Guldbrandtsen, B., Lund, M. S., & Sahana, G. (2018) · BMC Genetics · doi:10.1186/s12863-018-0620-0 · Cited by 12
“This gene was found to play a pivot role in controlling cell proliferation [29] and tumor suppression [30] in human studies.”
BackgroundRetractedThe NDR family of kinases: essential regulators of aging
Jonischkies, K., del Ángel, M., Demiray, Y. E., Zambrano, A. L., & Stork, O. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2024.1371086 · Cited by 10
Protein Post‐Translational Modification‐Mediated Control of Type I Interferon Cascade Signaling
Chen, X., Cheng, Q., Gong, F., & Zheng, H. (2025) · Medicine Bulletin · doi:10.1002/mdb2.70000 · Cited by 13
Yang, Y., Cao, Y. L., Wang, W. H., Shi, S. S., Zhang, Y. Y., Lv, B. B., Yang, W. W., Li, M., & Wei, D. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20183 · Cited by 10
“Genes encoding the mammalian sterile 20-like kinases (MST1/2) also negatively regulate YAP by activating LATS kinases through phosphorylation [17].”
BackgroundYang, P., Li, Y., Hou, J., Wu, D., Zeng, X. Z., Zeng, Z., Zhang, J., Xiong, Y., Chen, L., Yang, D., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107309 · Cited by 9
Oxford and the Savannah: Can the Hippo Provide an Explanation for Peto's Paradox?
Kelleher, F. C., & O’Sullivan, H. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-2010 · Cited by 9
“The signaling cascade of MST1/2 and LAT1/2 upstream of YAP are conserved in mammals (11-13).”
BackgroundCofré, J., Saalfeld, K., & Abdelhay, E. (2019) · The Scientific World JOURNAL · doi:10.1155/2019/4714781 · Cited by 13
“The canonical Hippo pathways [69], in vertebrate cells, act sequentially with MST1/2 and Lats1/2 [70, 71] to regulate the phosphorylation state of Yap1 (P, phosphate).”
BackgroundArun, A., Rayford, K. J., Cooley, A., Rachakonda, G., Villalta, F., Pratap, S., Lima, M. F., Sheibani, N., & Nde, P. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144912 · Cited by 9
You, W., Xu, Z., Di, A., Liu, P., Pang, C., Wang, J., Li, X., Wang, Y., Yu, B., Liu, X.-S., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5533914 · Cited by 11
O-GlcNAcylation: An Emerging Protein Modification Regulating the Hippo Pathway
Kim, E., Kang, J. G., Jho, E., Yang, W. H., & Cho, J. W. (2022) · Cancers · doi:10.3390/cancers14123013 · Cited by 12
“MOB1 phosphorylation causes the LATS1/2–MOB1 complex to dissociate from the MST1/2–SAV complex, and the released LATS1/2 are activated by the autophosphorylation of its activation loop (Ser909/Ser872) [40,41].”
BackgroundKong, F., Li, Y., Hu, E.-Z., Wang, R., Wang, J., Liu, J., Zhang, J., He, D., & Xiao, X. (2016) · PLoS ONE · doi:10.1371/journal.pone.0167080 · Cited by 11
Interplay of RAP2 GTPase and the cytoskeleton in Hippo pathway regulation
Wu, C., Cai, X., Wang, Y., Rodriguez, C. D., Zoaldi, G., Herrmann, L., Huang, C.-Y. C., Wang, X., Sanghvi, V. R., Lu, R. O., et al. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2024.107257 · Cited by 9
“4 F ), which is consistent with previous fi ndings (41 – 44).”
Downregulation of SSR2 Enhances Hepatocellular Carcinoma Cisplatin Sensitivity via the Hippo Pathway
Ye, R., Yin, L., Ge, Y., Zhu, X., Xiao, Y., Fang, C., Liu, Q., Zhang, H., Li, H., & Xie, B. (2024) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2908299 · Cited by 9
New Horizons in Cancer Progression and Metastasis: Hippo Signaling Pathway
Kuracha, M. R., Radhakrishna, U., Kuracha, S. V., Vegi, N., Gurung, J. L., & McVicker, B. L. (2024) · Biomedicines · doi:10.3390/biomedicines12112552 · Cited by 8
“Hippo Pathway Components MST1/2 is recruited to the plasma membrane by binding to their regulatory proteins SAV1/WW45 [25] .”
STRIPAK, a fundamental signaling hub of eukaryotic development
Kück, U., & Pöggeler, S. (2024) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00205-23 · Cited by 10
“12), the scaffolding protein Salvador (SAV1), and the adaptor protein MOB1 (209, 210).”
Liu, G., & Young, D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037221 · Cited by 8
Li, L., Gao, F., Jian, Y., Wang, X., Wang, X., Pan, L., Guo, W., Liu, D., & Hu, F. (2020) · Frontiers in Marine Science · doi:10.3389/fmars.2020.00418 · Cited by 8
PPP1R12A is a recycling endosomal phosphatase that facilitates YAP activation
Inoue, C., Mukai, K., Matsudaira, T., Nakayama, J., Kono, N., Aoki, J., Arai, H., Uchida, Y., & Taguchi, T. (2023) · Scientific Reports · doi:10.1038/s41598-023-47138-0 · Cited by 9
“Although the phosphorylated YAP increased, the active form of LATS1 (the phosphorylated LATS1 at Ser 909 21 ) was not affected in PPP1R12A-knockdown cells (Fig.”
BackgroundSirtuin 5-mediated deacetylation of TAZ at K54 promotes melanoma development
Kim, G., Bhattarai, P. Y., Lim, S., Lee, K. Y., & Choi, H. S. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00910-w · Cited by 9
“Further studies have revealed that LATSs and MSTs serve as upstream kinases of YAP and TAZ [48, 49], shifting the focus toward the expression and function of these kinases in various human cancers.”
S100A7 induction is repressed by YAP via the Hippo pathway in A431 cells
Li, Y., Kong, F., Wang, J., Hu, E.-Z., Wang, R., Liu, J., Xiao, Q., Zhang, W., He, D., & Xiao, X. (2016) · Oncotarget · doi:10.18632/oncotarget.9477 · Cited by 9
Ali, M., Khramushin, A., Yadav, V. K., Schueler‐Furman, O., & Ivarsson, Y. (2023) · Biochemistry · doi:10.1021/acs.biochem.3c00096 · Cited by 8
Kim, J., Kim, J., Kim, H., Jin, H., Yoo, Y., Fei, X., Maeng, H., Seo, S., Han, G., & No, K. T. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108425 · Cited by 7
VCPIP1 facilitates pancreatic adenocarcinoma progression via Hippo/YAP signaling
Liu, Z., Zhang, C., Gai, Y., Su, P., Wang, B., Liu, P., Wang, L., Lin, Y., Zhu, J., & Tan, X. (2025) · Cell Death and Disease · doi:10.1038/s41419-025-07746-2 · Cited by 9
“When Hippo signaling is activated, MST1/2 promotes the phosphorylation of LATS1/2 [9], which subsequently leads to the phosphorylation of YAP/TAZ [10].”
Hippo signaling in mechanobiology: Mechanical control of YAP/TAZ and their roles in disease
Kim, Y., Lee, H., Lee, J.-H., Kim, W., & Cha, B. (2026) · Mechanobiology · doi:10.1177/29780241261430920 · Cited by 10
Emami, S. S., Ge, A., Zhang, D., Hao, Y., Ling, M., Rubino, R., Nicol, C. J. B., Wang, W., & Yang, X. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25074064 · Cited by 7
“…initially identified in Drosophila as a novel regulator of animal size [1–9], has emerged as a signaling pathway with a central role in diverse biological processes, including tissue homeostasis [1–9], tumorigenesis [10,11], immune response [12], mechanotransduction [13], and drug resistance [14].”
BackgroundWang, S., Shao, D., Gao, X., Zhao, P., Kong, F., Deng, J., Yang, L., Shang, W., Sun, Y., & Fu, Z. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1480701 · Cited by 7
“The phosphorylation of downstream LATS1/2 is promoted by the activation of MST1/2 through its interaction with SAV1, thus initiating the kinase activity of the LATS1/2-MOB1 complex (92).”
BackgroundKlaihmon, P., Lorthongpanich, C., Kheolamai, P., Saisaard, W., & Issaragrisil, S. (2024) · Scientific Reports · doi:10.1038/s41598-024-54728-z · Cited by 7
Sun, Y., Wei, H., Yu, W., Gao, H., Li, J., Li, X., Zhang, H., Zhang, H., Miao, S., Zhao, L., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000001063 · Cited by 6
Xu, K., Zhu, S., Xu, F., Yang, J. W., Deng, B., Su, D., Ma, J., Zu, M., Lin, Y., Pei, T., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111312 · Cited by 6
“20 MST1/2 activation induces phosphorylation of LATS1/2, 21,22 followed by phosphorylation and cytoplasmic retention of YAP/TAZ, which suppresses the pro-proliferative and anti-apoptotic activities, thus facilitates apoptosis.”
Ye, J., Shi, M., Chen, W., Zhu, F., & Duan, Q. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200203115458 · Cited by 6
Regulation of TP73 transcription by Hippo-YAP signaling
Wen, Z., Wang, Y., Qi, S., Ma, M., Li, J., & Yu, F. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.07.132 · Cited by 6
Pu, J., Wang, F., Ye, P., Jiang, X., Zhou, W., Gu, Y., & Chen, S. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e11016 · Cited by 7
“phosphorylated by the upstream kinases MST1/2 and sequestered in the cytoplasm [9, 10, 11, 12].”
BackgroundDuong, N. X., Le, M., Kondo, T., & Mitsui, T. (2022) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17632 · Cited by 5
LATS in cancer repression: Extracting its role in hippo pathway and beyond
Akhtar, S. (2023) · Gene Reports · doi:10.1016/j.genrep.2023.101826 · Cited by 7
A Non-Canonical Hippo Pathway Represses the Expression of ΔNp63
Low-Calle, A. M., Ghoneima, H., Ortega, N., Cuibus, M. A., Katz, C., Tong, D., Prives, C., & Prywes, R. (2024) · Molecular and Cellular Biology · doi:10.1080/10985549.2023.2292037 · Cited by 5
“21 Activated LATS1/2 phosphorylate the transcriptional activators YAP and TAZ which are then sequestered in the cytoplasm and targeted for degradation.”
BackgroundBalavaishnavi, B., Kamaraj, M., Nithya, T. G., Santhosh, P., Gokilalakshmi, S., & Shaik, M. R. (2024) · Medical Oncology · doi:10.1007/s12032-024-02341-5 · Cited by 7
“ROS content will involve MST-1 for activating it because of this the MST-1 will phosphorylate Beclin-1 and involve with Bcl-2 and BAX for triggering apoptosis [37], On the other side the MST-1 will also phosphorylate LATS-1 this leads to the knockdown of YAP [47].”
Zhang, Q., Du, X., He, Q., Shi, W., Mei, L., Qv, M., Tan, D., Wu, J., Zeng, L., & Wu, X. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118655 · Cited by 5
Hippo signaling pathway in companion animal diseases, an under investigated signaling cascade
Budel, S. J., Penning, M. M., & Penning, L. C. (2021) · Veterinary Quarterly · doi:10.1080/01652176.2021.1923085 · Cited by 5
Shiraishi, Y., Maehama, T., Nishio, M., Otani, J., Hikasa, H., Mak, T. W., Sasaki, T., Honma, T., Kondoh, Y., Osada, H., et al. (2022) · Genes to Cells · doi:10.1111/gtc.12979 · Cited by 5
Zhang, Y., Ren, Y., Li, X., Li, M., Fu, M., Zhou, W., Yu, Y., & Xiong, Y. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.132473 · Cited by 5
Targeting the Hippo Pathway to Improve Response to Chemotherapy
Zhao, Y., & Yang, X. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813753-6.00008-1 · Cited by 6
Arioka, M., Yi, W., Igawa, K., Ishikane, S., & Takahashi‐Yanaga, F. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177184 · Cited by 4
Wang, X., Gu, Y., Zhong, Z., Yu, P., Liu, W., Zhu, R., Wang, Y., Zhou, Z., Sun, Y., Wang, X., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2517376122 · Cited by 4
Yang, P., & Li, S. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1610471 · Cited by 7
“Conversely, inactivation of the Hippo pathway (resulting in YAP/TAZ nuclear translocation) can enhance the expression of NF-κB target genes (e.g., pro-inflammatory factors IL-6 and TNF-α), thereby promoting the establishment of the tumor microenvironment (Chan et al., 2005; Hayden and Ghosh, 2008).”
Mechanisms of Hippo pathway in the pancreatic cancer
Xie, R., & Chen, R. (2020) · Journal of Pancreatology · doi:10.1097/jp9.0000000000000041 · Cited by 4
Wang, Y., & Rui, L. (2024) · Onco · doi:10.3390/onco4030016 · Cited by 4
Su, J.-X., Zhou, H., Zhang, Z., Zhou, X., Zou, Q.-M., Li, S., Zhuang, X.-S., Lai, J., Yang, S.-Y., Cui, K., et al. (2025) · Acta Pharmacologica Sinica · doi:10.1038/s41401-025-01514-w · Cited by 5
“Interestingly, p-MST1/2 levels were not affected by gracillin, despite MST1/2 is well characterized as an upstream activating kinase of LATS1/2 [35].”
Expression of Key Factors of the Hippo Signaling Pathway in Yak (Bos grunniens) Mammary Gland
Du, P., Lü, B., Zhao, L., Yao, Y., Qian, W., Yu, Z., Cui, Y., Yu, S., & Fan, J. (2022) · Animals · doi:10.3390/ani12162103 · Cited by 4
“MST1/2 in turn activates LATS1/2 via phosphorylation [21], which then phosphorylates the transcriptional coactivator YAP [22].”
BackgroundStamenkovic, I., & Yu, Q. (2009) · Elsevier eBooks · doi:10.1016/b978-012374178-3.10005-5 · Cited by 5
ZO-2 induces cytoplasmic retention of YAP by promoting a LATS1-ZO-2-YAP complex at tight junctionsPreprint
Liu, O. X., Lin, L. B., Chew, T., Motegi, F., & Low, B. C. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/355081 · Cited by 4
“The MST-1 and MST-2 kinases trigger phosphorylation and activation of the LATS kinases (Callus et al., 2006; Chan et al., 2005; Wei et al., 2007; Wu et al., 2003), which in turn phosphorylates and inactivates YAP and TAZ by restricting them to the cytoplasm (Dong et al., 2007; Huang et al., 2005;…”
BackgroundMicroRNA-135b mainly functions as an oncogene during tumor progression
Ghasaban, F. T., Taghehchian, N., Zangouei, A. S., Keivany, M. R., & Moghbeli, M. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2024.155547 · Cited by 4
Yang, Y., Xue, Z.-H., Lai, J., Zhang, J., Pang, C., Zhong, J., Kuang, Z., Zou, B., Liu, Y., & Sun, L. (2025) · Clinical and Translational Medicine · doi:10.1002/ctm2.70245 · Cited by 3
Zhang, G., Liu, Z., Xu, Y., Cao, F., Huo, X., Chen, Q., & Luo, D. (2025) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2025.117297 · Cited by 4
Ma, L., Gao, F., Dong, W., Song, Q., & Jia, Y. (2024) · Digestive Diseases · doi:10.1159/000536507 · Cited by 3
“Initially, MST1/2 forms a heterodimer with SAV1 and then phosphorylates SAV1, MOB1, LATS1, LATS2 [14 – 16], and YAP/TAZ effectors, leading to their inhibition of nuclear localization [14, 17].”
BackgroundA ZO ‐2 scaffolding mechanism regulates the Hippo signalling pathway
Liu, O. X., Lin, L. B., Bunk, S., Chew, T., Wu, S. K., Motegi, F., & Low, B. C. (2024) · FEBS Journal · doi:10.1111/febs.17304 · Cited by 4
Crystallization and preliminary X-ray crystallographic study of the human MST2 SARAH domain
Song, J., Hong, H., Choi, S., Lee, Y. H., Yamashita, E., Bae, S., Park, I. Y., & Lee, S. J. (2011) · Acta Crystallographica Section F Structural Biology and Crystallization Communications · doi:10.1107/s1744309111033823 · Cited by 3
“Autophosphorylated MST1/2 interacts with Salvador (Sav)/WW45 for translocation into the nucleus to activate LATS1/2 (Chan et al., 2005), which results in the downregulation of transcription factors via phosphorylation and inactivation of YAP (the transcription coactivator yes-associated protein).”
BackgroundAharoni‐Kats, L., Zelinger, E., Chen, S., & Yarden, O. (2018) · Molecular Microbiology · doi:10.1111/mmi.13954 · Cited by 3
Drastichová, Z., Trubacova, R., & Novotný, J. (2022) · Cells · doi:10.3390/cells11091473 · Cited by 3
“Although Stk3 (Mst2) kinase, whose phosphosite Ser316 was hyperphosphorylated in β-arrestin2-deficient cells and hypophosphorylated in TAL-treated cells (Figure 1, Tables S6 and S8), phosphorylates some phosphosites in Lats1; phosphosite Ser1111 was excluded as a site regulated by Stk3 [54].”
BackgroundInfluentialNader, N. A., Jakuc, N., Meinsohn, M.-C., Charrier, L., Banville, L., Brind’Amour, J., Paquet, M., St‐Jean, G., Boerboom, D., Mao, J., et al. (2025) · Endocrinology · doi:10.1210/endocr/bqaf077 · Cited by 2
Zgórzyńska, E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27083672 · Cited by 2
“MOB1A/B phosphorylation enhances its binding to LATS1/2 and initiates a cascade of activating autophosphorylation events within LATS kinases [30,31].”
Li, Y., Xu, Y., & Lu, P. (2023) · International Journal of General Medicine · doi:10.2147/ijgm.s412155 · Cited by 3
Regulation of YAP and TAZ Transcription Co-activators
Yu, F., Zhao, B., & Guan, K. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6220-0_5 · Cited by 2
DREF, a Concertmaster for Hippo Pathway and JNK Pathway in Drosophila
Fujiwara, S. (2013) · Journal of Carcinogenesis & Mutagenesis · doi:10.4172/2157-2518.1000e110 · Cited by 3
Alexander, S., Mathie, A. A., & Peters, J. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01649_9.x · Cited by 3
IGF2 mediates Hippo signaling to control liver sizePreprint
Zhong, Z., Jin, R., Zhong, Y., Zhang, L., Chen, D., Jiao, Z., Zhou, F., Zhu, R., Wu, J., Dong, R., et al. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.10.27.620455 · Cited by 2
YAP‐LAMB3 axis dictates cellular resistance of pancreatic ductal adenocarcinoma cells to gemcitabine
Li, Y., Wang, X., Yu, H.-P., Cao, J., Xie, J., Zhou, J., Feng, Z., & Chen, W. (2024) · Molecular Carcinogenesis · doi:10.1002/mc.23785 · Cited by 1
Metadata
- Authors
- Chan, E. H. Y., Nousiainen, M., Chalamalasetty, R. B., Schäfer, A., Nigg, E. A., & Silljé, H. H. W.
- Affiliations
- Max Planck Society (DE)
- Corresponding author
- Silljé, Herman H W
- Venue
- Oncogene
- Published
- 2005-01-31
- Volume
- 24
- Issue
- 12
- Pages
- 2076-2086
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2105193974
- Cited by
- 584
- References
- 42
- Citations by year
- 2026: 18 · 2025: 21 · 2024: 41 · 2023: 19 · 2022: 37 · 2021: 39 · 2020: 40 · 2019: 36 · 2018: 39 · 2017: 26 · 2016: 36 · 2015: 35 · 2014: 22 · 2013: 29 · 2012: 24
- FWCI
- 8.13
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Funders
- Croucher Foundation
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- MST2, LATS1, LATS2, Ste20-like kinase, Hippo signaling pathway, Warts kinase, kinase activation, phosphorylation sites, catalytic domain, tumor suppressor kinase, cell cycle regulation, apoptosis
- MeSH terms
- Serine-Threonine Kinase 3, Hippo Kinases, Amino Acid Sequence, Animals, Cell Line, Drosophila melanogaster, Gene Expression Regulation, HeLa Cells, Humans, Kidney, Peptide Fragments, Genes, Tumor Suppressor, Protein Serine-Threonine Kinases, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Tumor Suppressor Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.